Kintara Therapeutics KTRA

Quarterly report 2026-Q1
added 05-15-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ CAPITAL

Shares	47.9 M
Market Cap^[1]	$ 199 M
EBITDA (LTM)	$ 68.5 K
P/E (LTM)	-
P/S (LTM)	-
EPS (LTM)	-0.63

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.